Title
Novel Therapeutic Targets for Antiarrhythmic Drugs,Used
Delivery time: 8-12 business days (International)
PROFILES POTENTIAL TREATMENT APPROACHES FOR CARDIAC ARRHYTHMIASCardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology.Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a onestop guide that brings together previously dispersed information. The text consists of four sections: Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. Section Two addresses safety pharmacology, including the concept of 'repolarization reserve,' safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and nonion channel targets. Section Four describes promising nonpharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega3 fatty acids).Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.
By changing our most important processes and
products, we have already made a big leap forward. This ranges from the
increased use of more sustainable fibers to the use of more
environmentally friendly printing processes to the development of
efficient waste management in our value chain.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
Shipping & Returns
Shipping
We ship your order within 2–3 business days for USA deliveries and 5–8 business days for international shipments. Once your package has been dispatched from our warehouse, you'll receive an email confirmation with a tracking number, allowing you to track the status of your delivery.
Returns
To facilitate a smooth return process, a Return Authorization (RA) Number is required for all returns. Returns without a valid RA number will be declined and may incur additional fees. You can request an RA number within 15 days of the original delivery date. For more details, please refer to our Return & Refund Policy page.
Shipping & Returns
Shipping
We ship your order within 2–3 business days for USA deliveries and 5–8 business days for international shipments. Once your package has been dispatched from our warehouse, you'll receive an email confirmation with a tracking number, allowing you to track the status of your delivery.
Returns
To facilitate a smooth return process, a Return Authorization (RA) Number is required for all returns. Returns without a valid RA number will be declined and may incur additional fees. You can request an RA number within 15 days of the original delivery date. For more details, please refer to our Return & Refund Policy page.
Warranty
We provide a 2-year limited warranty, from the date of purchase for all our products.
If you believe you have received a defective product, or are experiencing any problems with your product, please contact us.
This warranty strictly does not cover damages that arose from negligence, misuse, wear and tear, or not in accordance with product instructions (dropping the product, etc.).
Warranty
We provide a 2-year limited warranty, from the date of purchase for all our products.
If you believe you have received a defective product, or are experiencing any problems with your product, please contact us.
This warranty strictly does not cover damages that arose from negligence, misuse, wear and tear, or not in accordance with product instructions (dropping the product, etc.).
Secure Payment
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
We accept payments with :
Visa, MasterCard, American Express, Paypal, Shopify Payments, Shop Pay and more.
Secure Payment
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
We accept payments with :
Visa, MasterCard, American Express, Paypal, Shopify Payments, Shop Pay and more.
Related Products
You may also like
Frequently Asked Questions
- Q: What is the main focus of 'Novel Therapeutic Targets for Antiarrhythmic Drugs'? A: The book focuses on potential treatment approaches for cardiac arrhythmias, including both pharmacological and non-pharmacological interventions.
- Q: Who is the author of this book? A: The author of 'Novel Therapeutic Targets for Antiarrhythmic Drugs' is George Edward Billman.
- Q: What is the publication date of this book? A: This book was published on January 7, 2010.
- Q: How many pages does 'Novel Therapeutic Targets for Antiarrhythmic Drugs' have? A: The book contains 608 pages.
- Q: What binding type does this book have? A: The book is available in hardcover binding.
- Q: What topics are covered in the book? A: The book covers basic cardiac electrophysiology, safety pharmacology, novel pharmacological targets, and non-pharmacological interventions for antiarrhythmic drugs.
- Q: Is this book suitable for both practitioners and researchers? A: Yes, it serves as a valuable resource for both practitioners and researchers in the field of cardiac arrhythmias.
- Q: Does the book discuss safety challenges in developing antiarrhythmic drugs? A: Yes, the book addresses safety pharmacology and regulatory issues related to the development of novel antiarrhythmic drugs.
- Q: What are some non-pharmacological interventions mentioned in the book? A: The book discusses interventions such as selective cardiac neural disruption, aerobic exercise training, and dietary recommendations like omega-3 fatty acids.
- Q: What edition of the book is available? A: The book is available in its first edition.